Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature

Elevated mammalian target of rapamycin (mTOR) signaling has been found in Alzheimer's disease (AD) patients and is linked to diabetes and aging, two known risk factors for AD. However, whether hyperactive mTOR plays a role in the cognitive deficits associated with AD remains elusive. Here, we g...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Caccamo, Antonella, De Pinto, Vito, Messina, Angela, Branca, Caterina, Oddo, Salvatore
Format: Artigo
Sprache:Inglês
Veröffentlicht: Society for Neuroscience 2014
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4044255/
https://ncbi.nlm.nih.gov/pubmed/24899720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.0777-14.2014
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge